)
IPERION (IPR) investor relations material
IPERION AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting held virtually with voting by poll and proxy forms accepted until 4:00 P.M.
Apologies noted from two directors; only one present to lead the meeting.
Meeting included welcome, introductions, formalities, a shareholder presentation, Q&A, and resolutions.
Financial performance review
No interest income in 2026 as cash was kept liquid for anticipated sales orders.
Outsourced manufacturing fee fully discounted for 2026 and will remain so through March 2028.
Admin expenses stable or decreased, with savings in travel and audit fees but higher stock exchange costs.
Net loss for the year was $294,595, with net assets at $53,803 and cash/term deposits at $155,492 as of March 2026.
No impairment expenses for 2026; trademark registration costs completed.
Board and executive committee updates
Directors and management are deferring 50% of their fees, and 33% of management fees, to conserve cash since January 2026.
No changes in the number of shares on issue.
- Net loss improved 35% year-over-year, driven by cost savings and deferred director fees.IPR
H2 2026 - Pathoglaze® achieved global certifications and broad trials as financials reflected higher costs.IPR
Investor presentation - Resolutions passed, financials tightened, and Pathoglaze advanced toward commercial rollout.IPR
Investor presentation - Net loss narrowed to $158,254 with no revenue and net tangible assets per share halved.IPR
H1 2026 - Net loss halved, costs reduced, and focus shifts to securing sales from product trials.IPR
H2 2025 - Net loss narrowed with no revenue, lower costs, and no dividend declared for the half year.IPR
H1 2025
Next IPERION earnings date
Next IPERION earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)